Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NARI NASDAQ:UPST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNARIInari Medical$79.97$79.97$39.76▼$79.99$4.68B1.021.49 million shsN/AUPSTUpstart$63.08+1.4%$72.34$31.40▼$96.43$6.07B2.375.96 million shs7.08 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNARIInari Medical0.00%0.00%0.00%0.00%+77.44%UPSTUpstart0.00%-5.71%-1.17%+21.26%+79.51%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNARIInari Medical$79.97$79.97$39.76▼$79.99$4.68B1.021.49 million shsN/AUPSTUpstart$63.08+1.4%$72.34$31.40▼$96.43$6.07B2.375.96 million shs7.08 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNARIInari Medical0.00%0.00%0.00%0.00%+77.44%UPSTUpstart0.00%-5.71%-1.17%+21.26%+79.51%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNARIInari Medical 2.09Hold$72.57-9.25% DownsideUPSTUpstart 2.36Hold$78.5424.51% UpsideCurrent Analyst Ratings BreakdownLatest UPST and NARI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/20/2025UPSTUpstartJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Overweight$93.00 ➝ $88.008/6/2025UPSTUpstartMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingEqual Weight8/6/2025UPSTUpstartPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$75.00 ➝ $90.008/6/2025UPSTUpstartMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$50.00 ➝ $70.008/6/2025UPSTUpstartNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$70.00 ➝ $82.008/6/2025UPSTUpstartBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$88.00 ➝ $87.007/14/2025UPSTUpstartThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell$71.006/24/2025UPSTUpstartPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOverweight$75.00(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNARIInari Medical$493.63M9.48$0.09 per share906.95$8.07 per share9.91UPSTUpstart$844.07M7.19N/AN/A$6.94 per share9.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNARIInari Medical-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%N/AUPSTUpstart-$128.58M-$0.08N/A67.83N/A-0.75%-5.95%-1.75%11/6/2025 (Estimated)Latest UPST and NARI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025UPSTUpstart$0.27$0.36+$0.09$0.05$225.35 million$257.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNARIInari MedicalN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNARIInari MedicalN/A1.771.40UPSTUpstartN/A0.430.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNARIInari Medical90.98%UPSTUpstart63.01%Insider OwnershipCompanyInsider OwnershipNARIInari Medical10.60%UPSTUpstart16.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNARIInari Medical80058.54 million52.34 millionOptionableUPSTUpstart1,19396.22 million80.18 millionOptionableUPST and NARI HeadlinesRecent News About These CompaniesUpstart Holdings, Inc. (NASDAQ:UPST) Short Interest Up 28.1% in AugustSeptember 10, 2025 | americanbankingnews.comUpstart Holdings, Inc. (UPST) Presents At Goldman Sachs Communicopia + Technology Conference 2025 TranscriptSeptember 8, 2025 | seekingalpha.comPrediction: Upstart Will Triple by 2030. Here's the Key Catalyst.September 7, 2025 | fool.comUpstart Holdings, Inc. (NASDAQ:UPST) Receives Average Rating of "Hold" from AnalystsSeptember 7, 2025 | americanbankingnews.comUpstart May Be A Future Victim Of AI - Downgrade To SellSeptember 6, 2025 | seekingalpha.comKBRA Assigns Preliminary Ratings to Upstart Securitization Trust 2025-3September 5, 2025 | businesswire.comUpstart's AI Underwriting Edge: Can It Keep Driving Loan Growth?September 5, 2025 | zacks.comIs UPST Stock a Buy, Hold, or Sell After Its 43.7% Three-Month Rally?September 2, 2025 | zacks.comInvestors Heavily Search Upstart Holdings, Inc. (UPST): Here is What You Need to KnowAugust 28, 2025 | zacks.comUpstart's Business Grew 154% Year Over Year, So Why Is the Stock Down?August 23, 2025 | fool.com3 Brilliant Fintech Stocks to Buy Now and Hold for the Long TermAugust 23, 2025 | fool.comWhy Upstart Rallied TodayAugust 22, 2025 | fool.comMy 5 Favorite Stocks to Buy Right NowAugust 22, 2025 | fool.comWhat Upstart's Earnings Say About the Health of Its BusinessAugust 21, 2025 | fool.com4 Fintech Growth Stocks to Buy With $260 and Hold ForeverAugust 19, 2025 | fool.comUpstart: GAAP Inflection PointAugust 18, 2025 | seekingalpha.comUpstart Stock Dropped After Earnings -- Could It Be a Screaming Bargain Right Now?August 17, 2025 | fool.comBetter Fintech Stock: Upstart vs. SoFi TechnologiesAugust 17, 2025 | fool.comThis Under-the-Radar AI Stock Could Double Your Money by 2028August 16, 2025 | fool.com3 Growth Stocks That Could Be Worth $1 Million in 5 YearsAugust 16, 2025 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Upstart Stock Could Pop on a Short Squeeze SoonBy Gabriel Osorio-Mazilli | August 20, 2025UPST and NARI Company DescriptionsInari Medical NASDAQ:NARIInari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Upstart NASDAQ:UPST$63.08 +0.89 (+1.43%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$63.34 +0.26 (+0.41%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
